Introduction
Drug use disorders are common among adults receiving care for HIV in the United States, with approximately half reporting drug use in the past year and a quarter of drug users screening in for current drug dependence (Bing et al., 2001) . Cocaine use, in particular, is associated with increased likelihood of engaging in behaviors, such as risky sex and treatment non-adherence, that are associated with HIV disease transmission and progression (Arnsten et al., 2002; Harzke et al., 2009; Hinkin et al., 2007; Tucker et al., 2004) . Cocaine use is also associated with poor HIV clinical outcomes, including higher viral load, CD4 cell count decline, AIDS-related illnesses, and death (Baum et al., 2009; Cook et al., 2008; Webber et al., 1999) . Many cocaine users do not receive substance abuse treatment (SAMSHA, 2008) ; dropout rates are high among those who do (Kampman et al., 2001; Siqueland et al., 2002) ; and there are no FDA-approved pharmacological treatments for cocaine dependence. Thus, HIV patients with cocaine dependence are at a particularly high risk for poor clinical and behavioral outcomes.
The high rate of impulsivity observed in cocaine users may help to explain continued engagement in health risk behaviors. Delay discounting is a measure of cognitive impulsivity that describes the relationship between the delay of a reward and its perceived value (Ainslie, 1975) . Greater impulsivity is defined as a preference for smaller immediate rewards over larger delayed rewards (Rachlin and Green, 1972) . Decision-making is central to this conceptualization, as immediate reward contingencies and future outcomes influence behavioral choice. Prior research has found that individuals who use drugs, including cocaine, methamphetamine, and heroin, are more cognitively impulsive than healthy controls or former users (Coffey et al., 2003; Heil et al., 2006; Hoffman et al., 2006; Kirby and Petry, 2004) .
While numerous studies have examined behavioral aspects of delay discounting, its underlying neurobiology is less well understood. Functional magnetic resonance imaging (fMRI) studies in healthy adults suggest that cortical areas, particularly the lateral prefrontal and posterior parietal cortices, are involved in hard decisions between similarly valued immediate and delayed rewards (McClure et al., 2004; Tanaka et al., 2004) . Only two studies have examined neural activity associated with delay discounting in drug users compared to healthy controls, and both focused on methamphetamine. These studies found that hard choices are associated with bilateral activation in the dorsal and ventral lateral prefrontal cortices Psychiatry Research: Neuroimaging 192 (2011) 167-175 
